Cystic fibrosis-focused Sionna Therapeutics is joining the Nasdaq this morning with an upsized public offering, while obesity ...

Titan America SA and its owner Titan Cement International SA raised $384 million in an initial public offering, pricing its ...

RenovoRx Inc. (RNXT) announced the pricing of a firm commitment, underwritten public offering of about 11.52 million shares of its ...

Volcon, Inc. (Nasdaq:VLCN) (the “Company”), the first all-electric, off-road powersports company, today announced the closing of its previously announced firm commitment underwritten public offering.

Diagnostyka SA’s shares surged in the Polish laboratory operator’s Warsaw debut, signaling a solid start for one of Europe’s ...

RenovoRx, Inc. (“RenovoRx” or the “Company”) (Nasdaq: RNXT), a life sciences company developing novel targeted oncology therapies and commercializing ...

Mustang Bio (MBIO) announced the pricing of a public offering of an aggregate of 2,657,807 shares of its common stock, Series C-1 warrants to ...

Swiss biotech Bioversys AG shares started trading at 36.5 Swiss francs ($40.29) on the SIX Swiss Exchange on Friday, slightly up from the final price for its initial public offering (IPO) of 36 Swiss ...

Titan America has raised $384 million after pricing its U.S. initial public offering at $16 per share, within its targeted range, the cement producer said on Thursday.

According to CEO Srikrishna Ramakarthikeyan, the re-listing of the mid-tier IT company will not change its focus or business ...

BOULDER, Colo., Feb. 06, 2025 (GLOBE NEWSWIRE) -- Gaia, Inc. (NASDAQ: GAIA) ("Gaia” or the "Company”), a conscious media and community company, announced today that it has priced its underwritten ...